瑞立科密(001285) - 2025年12月16日投资者关系活动记录表

Group 1: Company Overview - The company is a leading player in the domestic commercial vehicle active safety system market, focusing on products such as pneumatic ABS/ESC/EBS, electronic air suspension systems (ECAS), and intelligent driving products (AEBS) [4] - In 2024, the revenue from pneumatic control systems reached CNY 890.10 million, accounting for 55.63% of the active safety system business [4] - The hydraulic control systems for passenger vehicles generated revenue of CNY 149.28 million, representing 9.33% of the active safety system business [4] Group 2: Market Growth and Demand - The market growth is driven by increasing penetration of new energy and intelligent driving in commercial vehicles, leading to higher demand for advanced active safety braking systems [4] - Mandatory installation policies for ESC, EBS, and AEBS in more commercial vehicle models are accelerating the market adoption of high-value active safety braking products [4] - The motorcycle and two-wheeler market is also benefiting from mandatory installation policies and rising safety demands from consumers [4] Group 3: Competitive Advantages - The company has a strong technical advantage with over 20 years of experience in the commercial vehicle pneumatic braking field, accumulating extensive real-world data [6] - The company has developed a mature software algorithm system for its electronic control units (ECU), enabling precise braking control [6] - The company holds 459 authorized patents, including 58 invention patents, and has participated in the formulation of 9 national and industry standards [6] Group 4: Supply Chain and Cost Management - The company employs a diversified supply chain management strategy to control procurement costs, including a multi-supplier competition system [12] - Continuous business negotiations and technical cost reduction efforts are implemented to lower procurement costs [12] Group 5: Research and Development - The company maintains a high level of R&D investment, with R&D expenses reaching CNY 116 million in 2024 [13] - The R&D team consists of 384 personnel, supporting technological advancements [13] - Collaborations with universities and research institutions are in place to enhance R&D capabilities [13] Group 6: Financial Performance and Market Strategy - The company reported stable growth in revenue and net profit for Q3 2025, with a high net asset value per share [14] - To boost investor confidence in the secondary market, the company plans to enhance core business R&D and operational efficiency while exploring new strategic opportunities [15]